Skip to main content
2026 PALTmed Annual Conference Main banner
Evaluation

Deprescribing and Medication Optimization

(CME114) Prescribing Memory Loss? From Harm to Healing: Implementing Solutions to Anticholinergic Overuse

Thursday, March 26, 2026
2:30 PM - 4:00 PM PT
Room: Platinum Ballroom 3-4
CE: 1.5
CMD Clinical Credit Recording
CME: (1.5) MOC: (1.5) CMD Clinical: (1.5) AAFP (1.5)
Session Summary: This session explores the impact of anticholinergic burden (ACB) on dementia risk, functional decline, and mortality in frail older adults. We’ll review recent evidence, ACB scales, and the pharmacologic underpinnings of toxicity. Through real-world case studies and audience participation, attendees will practice deprescribing strategies that align with goals of care, dementia prevention, and medication optimization. A featured program initiative will be shared with replicable steps for implementation in their own practice equipping clinicians with practical, evidence-based tools to apply immediately upon return. This session will also follow the Age-Friendly, 4 Ms Framework endorsed by PALTmed, American Geriatrics Society, and the American Society of Consultant Pharmacists.

Learning Objectives:

At the completion of this session, learners will be able to:
  • After participating in this session, learners will be able to identify key signs and symptoms of chronic anticholinergic toxicity in older adults using patient scenarios and drug class examples.
  • Participants will be able to evaluate and calculate anticholinergic burden using at least one validated risk scale and apply this assessment to real-world patient cases to inform deprescribing decisions.
  • By the end of the session, learners will be able to develop and justify deprescribing strategies aligned with patient goals of care, incorporating pharmacologic principles and practical communication approaches.